Literature DB >> 31582221

Prolonged hypoxia decreases nuclear pyruvate dehydrogenase complex and regulates the gene expression.

Kayoko Eguchi1, Koh Nakayama2.   

Abstract

Cells require proper regulation of energy metabolism to maintain cellular homeostasis. Pyruvate dehydrogenase (PDH) is a metabolic enzyme that converts pyruvate into acetyl-CoA, connecting glycolysis to the TCA cycle, thus regulating cellular energy metabolism. PDH is involved in multiple cellular processes, such as glucose metabolism, fatty acid synthesis, and protein acetylation, all of which are mediated by acetyl-CoA. We previously demonstrated that PDH-E1β is downregulated in prolonged hypoxia and inhibits PDH activity, which serves as machinery to securely inhibit PDH activity together with PDH-E1α phosphorylation. PDH has been identified to localize to the nucleus in addition to mitochondria, but its precise regulatory mechanisms in the nucleus remain elusive. In the present study, we characterized nuclear PDH during prolonged hypoxia. Nuclear PDH complex was downregulated under hypoxic conditions, and PDH activity was reduced. Depletion of HIF-1α partly recovered nuclear levels of the PDH complex. Furthermore, decreased nuclear PDH activity resulted in reduced histone H3 acetylation, altering the gene expression profile of cells exposed to prolonged hypoxia. Taken together, these findings indicate that nuclear PDH complex is downregulated under prolonged hypoxic conditions and controls gene expression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Histone acetylation; Hypoxia; Nucleus; PDH complex; Pyruvate dehydrogenase

Year:  2019        PMID: 31582221     DOI: 10.1016/j.bbrc.2019.09.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages.

Authors:  Hyunju Kang; Young-Ki Park; Ji-Young Lee
Journal:  Lab Invest       Date:  2021-04-12       Impact factor: 5.662

Review 2.  Dihydrolipoamide dehydrogenase, pyruvate oxidation, and acetylation-dependent mechanisms intersecting drug iatrogenesis.

Authors:  I F Duarte; J Caio; M F Moedas; L A Rodrigues; A P Leandro; I A Rivera; M F B Silva
Journal:  Cell Mol Life Sci       Date:  2021-10-31       Impact factor: 9.261

3.  Delayed Impact of 2-Oxoadipate Dehydrogenase Inhibition on the Rat Brain Metabolism Is Linked to Protein Glutarylation.

Authors:  Alexandra I Boyko; Irina S Karlina; Lev G Zavileyskiy; Vasily A Aleshin; Artem V Artiukhov; Thilo Kaehne; Alexander L Ksenofontov; Sergey I Ryabov; Anastasia V Graf; Angela Tramonti; Victoria I Bunik
Journal:  Front Med (Lausanne)       Date:  2022-06-01

4.  Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma.

Authors:  Jun Inoue; Masahiro Kishikawa; Hitoshi Tsuda; Yasuaki Nakajima; Takahiro Asakage; Johji Inazawa
Journal:  Cancer Sci       Date:  2021-05-24       Impact factor: 6.716

Review 5.  Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer.

Authors:  Pasquale Saggese; Assunta Sellitto; Cesar A Martinez; Giorgio Giurato; Giovanni Nassa; Francesca Rizzo; Roberta Tarallo; Claudio Scafoglio
Journal:  Cancers (Basel)       Date:  2020-12-16       Impact factor: 6.639

Review 6.  Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer.

Authors:  Mio Harachi; Kenta Masui; Webster K Cavenee; Paul S Mischel; Noriyuki Shibata
Journal:  Metabolites       Date:  2021-04-01

7.  Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia.

Authors:  Yiyu Qin; Yongliang Zheng; Cheng Huang; Yuanyuan Li; Min Gu; Qin Wu
Journal:  Front Oncol       Date:  2021-08-16       Impact factor: 6.244

Review 8.  Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1.

Authors:  Minxuan Liu; Gina Galli; Yilin Wang; Qiru Fan; Zhenzhong Wang; Xin Wang; Wei Xiao
Journal:  Front Physiol       Date:  2020-07-15       Impact factor: 4.566

9.  FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.

Authors:  Huajun Xi; Zhengxiang He; Cao Lv
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.